Mostrar el registro sencillo del ítem

Relevance of infections on the outcomes of patients with myelodysplastic syndromes, chronic myelomonocytic leukemia, and acute myeloid leukemia treated with hypomethylating agents: a cohort study from the GESMD

dc.contributor.authorVilorio Marques, Laura
dc.contributor.authorFernández, Christelle Castanon
dc.contributor.authorMora, Elvira
dc.contributor.authorBernal del Castillo, Teresa 
dc.date.accessioned2023-04-25T10:12:24Z
dc.date.available2023-04-25T10:12:24Z
dc.date.issued2022
dc.identifier.citationTherapeutic Advances in Hematology, 13 (2022); doi:10.1177/20406207221127547
dc.identifier.issn2040-6207
dc.identifier.issn2040-6215
dc.identifier.urihttp://hdl.handle.net/10651/67493
dc.description.statementofresponsibilityVilorio-Marqués, L., Castañón Fernández, C., Mora, E., Gutiérrez, L., Rey Bua, B., Jiménez Lorenzo, M.J., Díaz Beya, M., Vara Pampliega, M., Molero, A., Sánchez-García, J., Calabuig, M., Cedena, M.T., Chen-Liang, T., Díaz Santa, J.A., Padilla, I., Hernández, F., Díez, R., Asensi, P., Xicoy, B., Sanz, G., Valcárcel, D., Diez-Campelo, M., Bernal, T.
dc.language.isoeng
dc.relation.ispartofTherapeutic advances in hematology
dc.rights© 2022 Los autores
dc.rightsCC Reconocimiento - No Comercial 4.0 Internacional
dc.rights.urihttp://creativecommons.org/licenses/by-nc/4.0/
dc.sourceWOS:000863670500001
dc.titleRelevance of infections on the outcomes of patients with myelodysplastic syndromes, chronic myelomonocytic leukemia, and acute myeloid leukemia treated with hypomethylating agents: a cohort study from the GESMD
dc.typejournal article
dc.identifier.doi10.1177/20406207221127547
dc.relation.publisherversionhttp://dx.doi.org/10.1177/20406207221127547
dc.rights.accessRightsopen access
dc.type.hasVersionVoR


Ficheros en el ítem

untranslated

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

© 2022 Los autores
Este ítem está sujeto a una licencia Creative Commons